Hajed O. Alharbi

Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice

A. Clerk, P. Sugden, S. Fuller, 2022, bioRxiv.

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo

Daniel N. Meijles, O. Rackham, A. Clerk, 2021, bioRxiv.

The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension.

Daniel N. Meijles, M. Sheppard, A. Clerk, 2021, Clinical science.

Immunological Impact of CLI-095 on Dendritic Cell Maturation and Hypoxia-re-oxygenation induced inflammatory injury

H. Alharbi, Hajed O. Alharbi, 2017 .

Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in mice in vivo

A. Clerk, S. Chothani, S. Cooper, 2023, bioRxiv.

MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins

Daniel N. Meijles, L. McGuffin, A. Clerk, 2021, The Biochemical journal.